SCHEMBL6497044

SCHEMBL6497044

O=C(O)c1ccc2c(=O)cc(-c3ccccc3)oc2c1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TNKS O95271 6/20 0.74
CYP19A1 P11511 5/20 0.68
MAOB P27338 3/20 0.68
CA12 O43570 2/20 0.68
CA1 P00915 2/20 0.68
CA2 P00918 2/20 0.68
ABCB1 P08183 2/20 0.68
CYP1B1 Q16678 2/20 0.68
CA9 Q16790 2/20 0.68
CALM1 P0DP23 2/20 0.68
PKM P14618 2/20 0.68
FTO Q9C0B1 2/20 0.68
MAOA P21397 2/20 0.68
AKR1B10 O60218 1/20 0.68
CYP1A2 P05177 1/20 0.68
HSD17B1 P14061 1/20 0.68
AKR1B1 P15121 1/20 0.68
HSD17B3 P37058 1/20 0.68
XDH P47989 1/20 0.68
SMN1; SMN2 Q16637 5/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27784284 0.88 CYP19A1 (0.65) TNKSCYP19A1MAOBCA12CA1
SCHEMBL1177191 0.88 TNKS (0.74) TNKSCYP19A1MAOBCA12CA1
SCHEMBL11565093 0.85 TNKS (0.55) TNKSCYP19A1MAOBCA12CA1
Flavone SCHEMBL31086265 0.85 TNKS (0.89) TNKSCYP19A1MAOBCA12CA1
SCHEMBL2032421 0.85 TNKS (1.00) TNKSCYP19A1MAOBCA12CA1
SCHEMBL11562626 0.82 MAPT (0.72) TNKSCYP19A1MAOBCA12CA1
7-Hydroxyflavone SCHEMBL312148 0.81 CYP19A1 (1.00) TNKSCYP19A1MAOBCA12CA1
7-Hydroxyflavone SCHEMBL29678183 0.81 CYP19A1 (1.00) TNKSCYP19A1MAOBCA12CA1
SCHEMBL11561056 0.81 ALDH1A1 (0.53) TNKSCYP19A1MAOBCA12CA1
SCHEMBL11558273 0.81 TNKS (0.53) TNKSCYP19A1MAOBCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1301987-C 7-carboxy-flavone derivatives, preparation method and therapeutic use NEGMA LERADS (FR) 2007-02-28 CN disclosed
CN-1301987-C 7-carboxy-flavone derivatives, preparation method and therapeutic use NEGMA LERADS (FR) 2007-02-28 CN disclosed
US-6965039-B2 7-carboxy-flavone derivatives preparation method and therapeutic use NEGMA-LERADS (FR) 2005-11-15 US disclosed
US-6965039-B2 7-carboxy-flavone derivatives preparation method and therapeutic use NEGMA-LERADS (FR) 2005-11-15 US disclosed
US-20040059136-A1 7-carboxy-flavone derivatives preparation method and therapeutic use NEGMA-LERADS (FR) 2004-03-25 US disclosed
US-20040059136-A1 7-carboxy-flavone derivatives preparation method and therapeutic use NEGMA-LERADS (FR) 2004-03-25 US disclosed
CN-1468228-A 7-carboxy-flavone derivatives, preparation method and therapeutic use �ŵ����-�������˹�� 2004-01-14 CN disclosed
CN-1468228-A 7-carboxy-flavone derivatives, preparation method and therapeutic use �ŵ����-�������˹�� 2004-01-14 CN disclosed
EP-1212313-A1 7-CARBOXY-FLAVONE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE Negma-Lerads (FR) 2002-06-12 EP disclosed
WO-2002028851-A1 7-CARBOXY-FLAVONE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE NEGMA-LERADS (FR) 2002-04-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040059136-A1 7-carboxy-flavone derivatives preparation method and therapeutic use BCOR, CYP7B1, CYP21A2 TNKS 4664/4885CYP19A1 32/4885MAOB 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.